We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$13.3B
AUM Growth
+$909M
(+7.3%)
Cap. Flow
+$365M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
18.02%
Holding
1,758
New
284
Increased
677
Reduced
459
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$28.4M |
| 2 |
Wabtec
WAB
|
+$24.8M |
| 3 |
Kornit Digital
KRNT
|
+$21.3M |
| 4 |
American Express
AXP
|
+$18.2M |
| 5 |
Microsoft
MSFT
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MBLY
Mobileye N.V.
MBLY
|
+$60.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$25.7M |
| 3 |
W.W. Grainger
GWW
|
+$21.5M |
| 4 |
NORD
Nord Anglia Education, Inc.
NORD
|
+$17.5M |
| 5 |
Dave & Buster's
PLAY
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.81% |
| 2 | Technology | 16.26% |
| 3 | Financials | 13.98% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STBI
776
DELISTED
STURGIS BANCORP INC
STBI
| $909K | 0.01% |
55,921
| – | – |
|
777
Theriva Biologics
TOVX
$9.64M
| $906K | 0.01% |
183
-4
| -2% | -$19.9K |
|
778
Sanofi
SNY
$103B
| $902K | 0.01% |
18,824
+5,635
| +43% | +$269K |
|
779
FirstCash
FCFS
$8.85B
| $899K | 0.01% |
15,416
-221
| -1% | -$11.7K |
|
|
APTS
780
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $894K | 0.01% |
56,790
-310
| -0.5% | -$4.69K |
|
|
ALXN
781
DELISTED
Alexion Pharmaceuticals
ALXN
| $892K | 0.01% |
7,331
-1,439
| -16% | -$167K |
|
782
Axos Financial
AX
$5.77B
| $888K | 0.01% |
37,455
-7,050
| -16% | -$167K |
|
783
Citizens Financial Group
CFG
$30.3B
| $887K | 0.01% |
+24,859
| New | +$881K |
|
|
WBT
784
DELISTED
Welbilt, Inc.
WBT
| $883K | 0.01% |
+46,850
| New | +$916K |
|
785
L3Harris
LHX
$51.6B
| $880K | 0.01% |
8,064
-134
| -2% | -$14.8K |
|
786
Packaging Corp of America
PKG
$21.9B
| $879K | 0.01% |
7,890
-29
| -0.4% | -$2.92K |
|
787
Rockwell Automation
ROK
$53.4B
| $877K | 0.01% |
5,414
+293
| +6% | +$46.2K |
|
788
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $877K | 0.01% |
28,628
-7,328
| -20% | -$224K |
|
789
Devon Energy
DVN
$52.1B
| $861K | 0.01% |
26,939
-1,598
| -6% | -$58.4K |
|
790
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
| $857K | 0.01% |
16,766
| – | – |
|
|
DXYN
791
DELISTED
Dixie Group Inc
DXYN
| $856K | 0.01% |
191,968
+9,500
| +5% | +$38.5K |
|
|
ATHN
792
DELISTED
Athenahealth, Inc.
ATHN
| $851K | 0.01% |
+6,055
| New | +$756K |
|
793
WisdomTree US High Dividend Fund
DHS
$1.56B
| $849K | 0.01% |
12,420
-9,115
| -42% | -$624K |
|
|
PFPT
794
DELISTED
Proofpoint, Inc.
PFPT
| $848K | 0.01% |
9,761
+1,825
| +23% | +$150K |
|
795
RBC Bearings
RBC
$17.4B
| $844K | 0.01% |
8,293
+3,068
| +59% | +$307K |
|
796
Regeneron Pharmaceuticals
REGN
$78.5B
| $841K | 0.01% |
1,713
+79
| +5% | +$34.6K |
|
797
Freeport-McMoran
FCX
$90B
| $837K | 0.01% |
69,694
+38,980
| +127% | +$473K |
|
798
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.9B
| $834K | 0.01% |
20,350
+13,650
| +204% | +$559K |
|
799
Invesco Senior Loan ETF
BKLN
$6.97B
| $833K | 0.01% |
35,981
-2,124
| -6% | -$49.4K |
|
800
PACCAR
PCAR
$69.8B
| $833K | 0.01% |
18,917
-898
| -5% | -$38.8K |
|
Similar funds
SAM
VIA
William Blair & Company's Q2 2017 Portfolio in Review
As of Q2 2017, William Blair & Company held 1,758 positions worth $13.3B, up 7.3% from $12.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
William Blair & Company's Q2 2017 filing shows 284 new, 677 increased, 459 reduced and 116 closed positions. Its largest new stake was Bob Evans Farms, Inc.: 219,278 shares worth $15.8M. The largest sale was Mobileye N.V., an estimated $60.9M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- William Blair & Company's largest Q2 2017 buy was Bob Evans Farms, Inc.: 219,278 shares worth $15.8M.
- William Blair & Company added most to Alphabet (Google) Class A in Q2 2017, an estimated $28.4M increase.
- William Blair & Company's biggest Q2 2017 reduction was Mobileye N.V., cutting an estimated $60.9M.
- William Blair & Company fully exited Nord Anglia Education, Inc. in Q2 2017, selling an estimated $17.5M.
- William Blair & Company's ten largest holdings make up 18% of its $13.3B portfolio in Q2 2017.
- William Blair & Company opened 284 new positions and closed 116 in Q2 2017.
- William Blair & Company's portfolio value rose 7.3% quarter-over-quarter to $13.3B.
Based on William Blair & Company's 13F filing for Q2 2017, filed 4 Aug 2017.